Cargando…
Neoadjuvant systemic and intravesical chemotherapy with partial cystectomy for muscle invasive bladder cancer with concomitant CIS
The presence of carcinoma in situ (CIS) is traditionally a contraindication to bladder-sparing approaches for muscle invasive bladder cancer (MIBC). Strategies that might aid in bladder preservation for this population require further investigation. We report a case of MIBC with CIS treated with bot...
Autores principales: | Plambeck, Benjamin D., Tazegul, Tutku E., McElree, Ian M., Steinberg, Ryan L., Packiam, Vignesh T., O'Donnell, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461041/ https://www.ncbi.nlm.nih.gov/pubmed/37645679 http://dx.doi.org/10.1016/j.eucr.2023.102516 |
Ejemplares similares
-
Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer
por: McElree, Ian M., et al.
Publicado: (2023) -
Recurrent heterotopic ossification following open radical nephrectomy
por: Richards, Jordan R., et al.
Publicado: (2023) -
Clinical application and efficacy analysis of partial cystectomy combined with intravesical chemotherapy in muscle-invasive bladder cancer
por: Zhang, Bin, et al.
Publicado: (2023) -
Intravesical Treatments of Bladder Cancer: Review
por: Shen, Zancong, et al.
Publicado: (2008) -
Ongoing efforts to reduce perioperative morbidity of radical cystectomy: towards widespread adoption of extended-duration thromboprophylaxis
por: Packiam, Vignesh T., et al.
Publicado: (2018)